Idiopathic membranoproliferative glomerulonephritis: does it exist?

When membranoproliferative glomerulonephritis (MPGN) was first delineated as a discrete clinico-pathological entity more than a half-century ago, most cases were regarded as idiopathic (or primary) in nature. Advances in analysis of pathogenetic mechanisms and etiologies underlying the lesion of MPG...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nephrology, dialysis, transplantation dialysis, transplantation, 2012-12, Vol.27 (12), p.4288-4294
Hauptverfasser: FERVENZA, Fernando C, SETHI, Sanjeev, GLASSOCK, Richard J
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 4294
container_issue 12
container_start_page 4288
container_title Nephrology, dialysis, transplantation
container_volume 27
creator FERVENZA, Fernando C
SETHI, Sanjeev
GLASSOCK, Richard J
description When membranoproliferative glomerulonephritis (MPGN) was first delineated as a discrete clinico-pathological entity more than a half-century ago, most cases were regarded as idiopathic (or primary) in nature. Advances in analysis of pathogenetic mechanisms and etiologies underlying the lesion of MPGN have radically altered the prevalence of the truly idiopathic form of MPGN. In addition, MPGN as a category among renal biopsies showing glomerulonephritis has diminished over time. In the modern era, MPGN is mainly classified morphologically on the basis of immunoglobulin (Ig; monoclonal or polyclonal) and complement (C3 only or combined with Ig) deposition and secondarily on the basis of its appearance on ultra-structural examination. Idiopathic MPGN is a diagnosis of exclusion, at least in many adults and a portion of children, and a systematic approach to evaluation will often uncover a secondary cause, such as an infection, autoimmune disease, monoclonal gammopathy, neoplasia, complement dysregulation or a chronic thrombotic microangiopathy. Idiopathic MPGN remains an 'endangered species' after its separation from these known causes.
doi_str_mv 10.1093/ndt/gfs288
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1239060482</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1239060482</sourcerecordid><originalsourceid>FETCH-LOGICAL-c353t-1601704daaad4e31a5bb401303adc102c47925ac15ff9e3ccaea70c800045e8e3</originalsourceid><addsrcrecordid>eNpFkEtLxDAUhYMoOo5u_AHSjSBCnZukaVI3IoOPgQE3ui5pejsT6WNMUtF_b2RGXd3F-Tic-xFyRuGaQsFnfR1mq8YzpfbIhGY5pIwrsU8mMaQpCCiOyLH3bwBQMCkPyRFjslAC1ITMF7UdNjqsrUk67Cqn-2HjhtY26HSwH5is2qFDN7ZDj5u1s8H6m6Qe0Cc2JPhpfbg9IQeNbj2e7u6UvD7cv8yf0uXz42J-t0wNFzykNAcqIau11nWGnGpRVRlQDlzXhgIzmSyY0IaKpimQG6NRSzAqzs4EKuRTcrntjQPfR_Sh7Kw32La6x2H0JWW8gBwyxSJ6tUWNG7x32JQbZzvtvkoK5Y-0Mkort9IifL7rHasO6z_011IELnaA9ka3TZRkrP_ncplLiJ98A1mWdmU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1239060482</pqid></control><display><type>article</type><title>Idiopathic membranoproliferative glomerulonephritis: does it exist?</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Oxford University Press Journals All Titles (1996-Current)</source><source>Alma/SFX Local Collection</source><creator>FERVENZA, Fernando C ; SETHI, Sanjeev ; GLASSOCK, Richard J</creator><creatorcontrib>FERVENZA, Fernando C ; SETHI, Sanjeev ; GLASSOCK, Richard J</creatorcontrib><description>When membranoproliferative glomerulonephritis (MPGN) was first delineated as a discrete clinico-pathological entity more than a half-century ago, most cases were regarded as idiopathic (or primary) in nature. Advances in analysis of pathogenetic mechanisms and etiologies underlying the lesion of MPGN have radically altered the prevalence of the truly idiopathic form of MPGN. In addition, MPGN as a category among renal biopsies showing glomerulonephritis has diminished over time. In the modern era, MPGN is mainly classified morphologically on the basis of immunoglobulin (Ig; monoclonal or polyclonal) and complement (C3 only or combined with Ig) deposition and secondarily on the basis of its appearance on ultra-structural examination. Idiopathic MPGN is a diagnosis of exclusion, at least in many adults and a portion of children, and a systematic approach to evaluation will often uncover a secondary cause, such as an infection, autoimmune disease, monoclonal gammopathy, neoplasia, complement dysregulation or a chronic thrombotic microangiopathy. Idiopathic MPGN remains an 'endangered species' after its separation from these known causes.</description><identifier>ISSN: 0931-0509</identifier><identifier>EISSN: 1460-2385</identifier><identifier>DOI: 10.1093/ndt/gfs288</identifier><identifier>PMID: 22798508</identifier><identifier>CODEN: NDTREA</identifier><language>eng</language><publisher>Oxford: Oxford University Press</publisher><subject>Algorithms ; Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy ; Biological and medical sciences ; Emergency and intensive care: renal failure. Dialysis management ; Glomerulonephritis ; Glomerulonephritis, Membranoproliferative - classification ; Glomerulonephritis, Membranoproliferative - etiology ; Glomerulonephritis, Membranoproliferative - pathology ; Humans ; Intensive care medicine ; Medical sciences ; Nephrology. Urinary tract diseases ; Nephropathies. Renovascular diseases. Renal failure</subject><ispartof>Nephrology, dialysis, transplantation, 2012-12, Vol.27 (12), p.4288-4294</ispartof><rights>2014 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c353t-1601704daaad4e31a5bb401303adc102c47925ac15ff9e3ccaea70c800045e8e3</citedby><cites>FETCH-LOGICAL-c353t-1601704daaad4e31a5bb401303adc102c47925ac15ff9e3ccaea70c800045e8e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=26767001$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22798508$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>FERVENZA, Fernando C</creatorcontrib><creatorcontrib>SETHI, Sanjeev</creatorcontrib><creatorcontrib>GLASSOCK, Richard J</creatorcontrib><title>Idiopathic membranoproliferative glomerulonephritis: does it exist?</title><title>Nephrology, dialysis, transplantation</title><addtitle>Nephrol Dial Transplant</addtitle><description>When membranoproliferative glomerulonephritis (MPGN) was first delineated as a discrete clinico-pathological entity more than a half-century ago, most cases were regarded as idiopathic (or primary) in nature. Advances in analysis of pathogenetic mechanisms and etiologies underlying the lesion of MPGN have radically altered the prevalence of the truly idiopathic form of MPGN. In addition, MPGN as a category among renal biopsies showing glomerulonephritis has diminished over time. In the modern era, MPGN is mainly classified morphologically on the basis of immunoglobulin (Ig; monoclonal or polyclonal) and complement (C3 only or combined with Ig) deposition and secondarily on the basis of its appearance on ultra-structural examination. Idiopathic MPGN is a diagnosis of exclusion, at least in many adults and a portion of children, and a systematic approach to evaluation will often uncover a secondary cause, such as an infection, autoimmune disease, monoclonal gammopathy, neoplasia, complement dysregulation or a chronic thrombotic microangiopathy. Idiopathic MPGN remains an 'endangered species' after its separation from these known causes.</description><subject>Algorithms</subject><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</subject><subject>Biological and medical sciences</subject><subject>Emergency and intensive care: renal failure. Dialysis management</subject><subject>Glomerulonephritis</subject><subject>Glomerulonephritis, Membranoproliferative - classification</subject><subject>Glomerulonephritis, Membranoproliferative - etiology</subject><subject>Glomerulonephritis, Membranoproliferative - pathology</subject><subject>Humans</subject><subject>Intensive care medicine</subject><subject>Medical sciences</subject><subject>Nephrology. Urinary tract diseases</subject><subject>Nephropathies. Renovascular diseases. Renal failure</subject><issn>0931-0509</issn><issn>1460-2385</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkEtLxDAUhYMoOo5u_AHSjSBCnZukaVI3IoOPgQE3ui5pejsT6WNMUtF_b2RGXd3F-Tic-xFyRuGaQsFnfR1mq8YzpfbIhGY5pIwrsU8mMaQpCCiOyLH3bwBQMCkPyRFjslAC1ITMF7UdNjqsrUk67Cqn-2HjhtY26HSwH5is2qFDN7ZDj5u1s8H6m6Qe0Cc2JPhpfbg9IQeNbj2e7u6UvD7cv8yf0uXz42J-t0wNFzykNAcqIau11nWGnGpRVRlQDlzXhgIzmSyY0IaKpimQG6NRSzAqzs4EKuRTcrntjQPfR_Sh7Kw32La6x2H0JWW8gBwyxSJ6tUWNG7x32JQbZzvtvkoK5Y-0Mkort9IifL7rHasO6z_011IELnaA9ka3TZRkrP_ncplLiJ98A1mWdmU</recordid><startdate>20121201</startdate><enddate>20121201</enddate><creator>FERVENZA, Fernando C</creator><creator>SETHI, Sanjeev</creator><creator>GLASSOCK, Richard J</creator><general>Oxford University Press</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20121201</creationdate><title>Idiopathic membranoproliferative glomerulonephritis: does it exist?</title><author>FERVENZA, Fernando C ; SETHI, Sanjeev ; GLASSOCK, Richard J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c353t-1601704daaad4e31a5bb401303adc102c47925ac15ff9e3ccaea70c800045e8e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Algorithms</topic><topic>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</topic><topic>Biological and medical sciences</topic><topic>Emergency and intensive care: renal failure. Dialysis management</topic><topic>Glomerulonephritis</topic><topic>Glomerulonephritis, Membranoproliferative - classification</topic><topic>Glomerulonephritis, Membranoproliferative - etiology</topic><topic>Glomerulonephritis, Membranoproliferative - pathology</topic><topic>Humans</topic><topic>Intensive care medicine</topic><topic>Medical sciences</topic><topic>Nephrology. Urinary tract diseases</topic><topic>Nephropathies. Renovascular diseases. Renal failure</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>FERVENZA, Fernando C</creatorcontrib><creatorcontrib>SETHI, Sanjeev</creatorcontrib><creatorcontrib>GLASSOCK, Richard J</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Nephrology, dialysis, transplantation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>FERVENZA, Fernando C</au><au>SETHI, Sanjeev</au><au>GLASSOCK, Richard J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Idiopathic membranoproliferative glomerulonephritis: does it exist?</atitle><jtitle>Nephrology, dialysis, transplantation</jtitle><addtitle>Nephrol Dial Transplant</addtitle><date>2012-12-01</date><risdate>2012</risdate><volume>27</volume><issue>12</issue><spage>4288</spage><epage>4294</epage><pages>4288-4294</pages><issn>0931-0509</issn><eissn>1460-2385</eissn><coden>NDTREA</coden><abstract>When membranoproliferative glomerulonephritis (MPGN) was first delineated as a discrete clinico-pathological entity more than a half-century ago, most cases were regarded as idiopathic (or primary) in nature. Advances in analysis of pathogenetic mechanisms and etiologies underlying the lesion of MPGN have radically altered the prevalence of the truly idiopathic form of MPGN. In addition, MPGN as a category among renal biopsies showing glomerulonephritis has diminished over time. In the modern era, MPGN is mainly classified morphologically on the basis of immunoglobulin (Ig; monoclonal or polyclonal) and complement (C3 only or combined with Ig) deposition and secondarily on the basis of its appearance on ultra-structural examination. Idiopathic MPGN is a diagnosis of exclusion, at least in many adults and a portion of children, and a systematic approach to evaluation will often uncover a secondary cause, such as an infection, autoimmune disease, monoclonal gammopathy, neoplasia, complement dysregulation or a chronic thrombotic microangiopathy. Idiopathic MPGN remains an 'endangered species' after its separation from these known causes.</abstract><cop>Oxford</cop><pub>Oxford University Press</pub><pmid>22798508</pmid><doi>10.1093/ndt/gfs288</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0931-0509
ispartof Nephrology, dialysis, transplantation, 2012-12, Vol.27 (12), p.4288-4294
issn 0931-0509
1460-2385
language eng
recordid cdi_proquest_miscellaneous_1239060482
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Oxford University Press Journals All Titles (1996-Current); Alma/SFX Local Collection
subjects Algorithms
Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy
Biological and medical sciences
Emergency and intensive care: renal failure. Dialysis management
Glomerulonephritis
Glomerulonephritis, Membranoproliferative - classification
Glomerulonephritis, Membranoproliferative - etiology
Glomerulonephritis, Membranoproliferative - pathology
Humans
Intensive care medicine
Medical sciences
Nephrology. Urinary tract diseases
Nephropathies. Renovascular diseases. Renal failure
title Idiopathic membranoproliferative glomerulonephritis: does it exist?
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T02%3A34%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Idiopathic%20membranoproliferative%20glomerulonephritis:%20does%20it%20exist?&rft.jtitle=Nephrology,%20dialysis,%20transplantation&rft.au=FERVENZA,%20Fernando%20C&rft.date=2012-12-01&rft.volume=27&rft.issue=12&rft.spage=4288&rft.epage=4294&rft.pages=4288-4294&rft.issn=0931-0509&rft.eissn=1460-2385&rft.coden=NDTREA&rft_id=info:doi/10.1093/ndt/gfs288&rft_dat=%3Cproquest_cross%3E1239060482%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1239060482&rft_id=info:pmid/22798508&rfr_iscdi=true